Coherus Oncology
CHRS
51 hedge funds and large institutions have $222M invested in Coherus Oncology in 2015 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 11 closing their positions.
118% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 11
41% more capital invested
Capital invested by funds: $158M → $222M (+$64.1M)
34% more funds holding
Funds holding: 38 → 51 (+13)
18% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 11
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$14.2M |
| 2 |
Millennium Management
New York
|
+$7.26M |
| 3 |
CCI
Columbus Circle Investors
|
+$5.71M |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$4.21M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$4.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
-$49.9M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
-$12.7M |
| 3 |
PA
Perceptive Advisors
New York
|
-$9.12M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.09M |
| 5 |
Morgan Stanley
New York
|
-$1.49M |
CHRS Hedge Fund Activity: Q1 2015 in Review
51 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q1 2015, worth a combined $222M — up 41% from $158M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new CHRS positions and 11 closed out — a net gain of 13 holders — while 13 added to existing stakes and 11 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $14.2M. The largest seller was Kohlberg Kravis Roberts & Co, exiting entirely with an estimated $49.9M sold.
- 51 institutional investors held Coherus Oncology (CHRS) as of Q1 2015, up from 38 in Q4 2014.
- Funds reported $222M of Coherus Oncology stock for Q1 2015, up 41% quarter-over-quarter.
- 24 funds opened new Coherus Oncology positions in Q1 2015 and 11 closed out, a net change of +13 holders.
- The largest Coherus Oncology buyer in Q1 2015 was JP Morgan Chase, an estimated $14.2M added.
- The largest Coherus Oncology seller in Q1 2015 was Kohlberg Kravis Roberts & Co, an estimated $49.9M sold.
Based on aggregated 13F filings for Q1 2015.